Stock in news - Sunpharma

Sun Pharmaceuticals Industries Ltd on Thursday, April 10 said the US Court of Appeals for the Federal Circuit has ruled in favour of the company and vacated its preliminary injunction of delaying the launch of Leqselvi (deuruxolitinib), effective immediately. The medication is intended for treating severe alopecia areata. The US Court of Appeals for the Federal Circuit had held an oral argument on the company's appeal of the US District Court's decision that had previously granted the injunction in November 2024 Source- CNBC